ARTICLE | Company News
Peptinnovate, MRC deal
July 27, 2015 7:00 AM UTC
Peptinnovate and MRC partnered to evaluate the therapeutic potential of Pepinnovate’s peptides, which are derived from Mycobacterium tuberculosis, to treat bone diseases. The peptides will tested at M...